All Stories

  1. Rapid, portable, one-pot CRISPR/Dx system
  2. Opto-CRISPR technologies in translational neuropharmacology
  3. CRISPR technology for diagnosis and treatment of human brucellosis
  4. Rapid, multiplex, one-pot CRISPR/Dx system
  5. CRISPR/Dx-based colorimetric and electrochemical detection systems for POCT applications
  6. CRISPR-based platforms for detecting tumor-associated genetic materials in clinical samples
  7. Pan-cancer methylation analysis of circulating cell-free DNA
  8. Recent Advances in Gene Therapy for Hemophilia
  9. CRISPR/Cas-based personal glucose meters for nucleic acid detection
  10. A radiation toxicity biosensing platform based on radioresistant bacteria modified with dr_0423
  11. Artificial base mismatches-mediated PCR (ABM-PCR) for detecting clinically relevant single-base mutations
  12. Blood cancer therapy with synthetic receptors and CRISPR technology
  13. CRISPR detection of cardiac tumor-associated microRNAs
  14. One-pot isothermal CRISPR/Dx system for specific and sensitive detection of microRNA
  15. Rapid, multiplex, one-pot CRISPR/Dx system for detecting cancer fusion genes
  16. UV radiation enhanced encapsulation of superparamagnetic iron oxide nanoparticles (MNPs) in microparticles derived from tumor repopulating cells
  17. SynNotch-Programmed Macrophages for Cancerous Cell Detection and Sensing
  18. Amplification-free nucleic acids detection with next-generation CRISPR/dx systems
  19. Extended replicative lifespan of primary resting T cells by CRISPR/dCas9-based epigenetic modifiers and transcriptional activators
  20. Next-generation CRISPR technology for genome, epigenome and mitochondrial editing
  21. Development of a baculoviral CRISPR/Cas9 vector system for beta-2-microglobulin knockout in human pluripotent stem cells
  22. Rapid and Amplification-free Nucleic Acid Detection with DNA Substrate-Mediated Autocatalysis of CRISPR/Cas12a
  23. Effects of Different Surface Functionalizations of Silica Nanoparticles on Mesenchymal Stem Cells
  24. Multimodal detection of flap endonuclease 1 activity through CRISPR/Cas12a trans-cleavage of single-strand DNA oligonucleotides
  25. Cellular uptake, tissue penetration, biodistribution, and biosafety of threose nucleic acids: Assessing in vitro and in vivo delivery
  26. PAM-flexible dual base editor-mediated random mutagenesis and self-activation strategies to improve CRISPRa potency
  27. Multimodal Detection of Flap Endonuclease 1 Activity Through Crispr/Cas12a Trans-Cleavage of Single-Strand DNA Oligonucleotides
  28. Targeted brain tumor imaging by using discrete biopolymer-coated nanodiamonds across the blood–brain barrier
  29. CRISPR-based transgene knock-in and gene correction
  30. Correction to Penetrating the Blood–Brain Barrier by Self-Assembled 3D DNA Nanocages as Drug Delivery Vehicles for Brain Cancer Therapy
  31. Penetrating the Blood–Brain Barrier by Self-Assembled 3D DNA Nanocages as Drug Delivery Vehicles for Brain Cancer Therapy
  32. Synthetic α-l-Threose Nucleic Acids Targeting BcL-2 Show Gene Silencing and in Vivo Antitumor Activity for Cancer Therapy
  33. The Synergy between CRISPR and Chemical Engineering
  34. Targeted Transgene Activation in the Brain Tissue by Systemic Delivery of Engineered AAV1 Expressing CRISPRa
  35. Diverse CRISPR Applications
  36. In vivo epigenome editing and transcriptional modulation using CRISPR technology
  37. Dual-Function, Cationic, Peptide-Coated Nanodiamond Systems: Facilitating Nuclear-Targeting Delivery for Enhanced Gene Therapy Applications
  38. In vivo genome editing using AAV-CRISPR system
  39. Epigenetic studies using CRISPR technology
  40. Human aging research using CRISPR technology
  41. microRNA research using artificial microRNA sponges
  42. Optimization of baculoviral-TALEN system
  43. Cellular reprogramming using baculoviral-ZFN system
  44. Genetic manipulation of human iPSCs using baculoviral-ZFN system
  45. Genetic manipulation of human iPSCs using baculoviral-TALEN system
  46. Association of adiponectin and resistin gene polymorphisms with metabolic syndrome phenotypes
  47. Epistatic interactions between adiponectin and resistin gene polymorphisms
  48. Association of adiponectin and resistin gene polymorphisms with adipokine levels
  49. Novel adiponectin-resistin and insulin resistance indexes